Atlas Biotechnologieswill fund and provide support to three research projects at the University of Albertato possibly identify cannabis component(s) that could help people with neurological diseases likemultiple sclerosis (MS). The cannabis plant produces hundreds of biological compounds, the best-known being tetrahydrocannabinol (THC) the psychoactive compound primarily responsible for the cannabis high and cannabidiol (CBD), a main component of medical marijuana Continue reading →

Its always nice to hear about generics becoming available to replace expensive multiple sclerosis treatments. But I wonder whether these generics will cost less than the brand-name medication. Will their availability help to drive down the price of Gilenya (fingolimod)? Continue reading →

It was acute lymphoblastic leukemia. What are you talking about? she remembers telling the physician. Continue reading →

Canadian medical cannabis producer Atlas Biotechnologies has given a $300,000 grant to the University of Alberta for research into cannabis as a therapy for multiple sclerosis (MS), Alzheimers disease, and Huntingtons disease, the Edmonton Journal reports. Continue reading →

I rolled onto the neurology ward of the hospital that has been dealing with my disease from the beginning. The nurses, whom Ive met innumerable times, opened with their normal jolly, How are you? I can never resist, Well, I have got MS! It was 8 in the morning. Continue reading →

Then, at 11:15 p.m., he started climbing onto benches in the holding pen, a second official said. He was topless. Continue reading →

Biogen's (NASDAQ:BIIB) run on the stock market this year has been a roller-coaster ride, to say the least. In March, the company's shares fell off a cliff, decreasing by more than 30% in just a few days. In October, Biogen's stock went in the opposite direction, skyrocketing by 28% during the month Continue reading →